关注
Faris Hermawan
Faris Hermawan
National Research and Innovation Agency (BRIN), Indonesia
在 brin.go.id 的电子邮件经过验证
标题
引用次数
引用次数
年份
Design of thioxanthone derivatives as potential tyrosine kinase inhibitor: A molecular docking study
F Hermawan, J Jumina, HD Pranowo
Rasayan J. Chem 13, 2626-2632, 2020
82020
Molecular Docking Approach For Design and Synthesis of Thioxanthone Derivatives as Anticancer Agents
F Hermawan, Jumina, HD Pranowo, EN Sholikhah, MR Iresha
ChemistrySelect 7 (46), e202203076, 2022
32022
Synthesis, Cytotoxicity Evaluation and Molecular Docking Studies of Xanthyl-Cinnamate Derivatives as Potential Anticancer Agents
MR Iresha, J Jumina, HD Pranowo, EN Sholikhah, F Hermawan
Indonesian Journal of Chemistry, 2022
22022
Computational Design of Thioxanthone Derivatives as Potential Antimalarial Agents through Plasmodium falciparum Protein Inhibition
F Hermawan, J Jumina, HD Pranowo, EN Sholikhah, MR Iresha
Indonesian Journal of Chemistry, 2022
22022
In-silico Studies of Epoxy-Thioxanthone Derivatives as Potential Tyrosine Kinase Inhibitor Using Molecular Docking, Molecular Dynamics Simulations, MM-PBSA …
F Hermawan, J Jumina, HD Pranowo, T Ernawati, YS Kurniawan, AT Zikri
Brazilian Journal of Pharmaceutical Sciences 60, e23797, 2024
2024
In silico Approach for Design, Synthesis and Biological Evaluation of Tioxanthone Derivatives as Potential Anticancer Agents
F Hermawan, J Jumina, HD Pranowo, EN Sholikhah, T Ernawati, ...
ChemistrySelect 9 (6), e202304014, 2024
2024
In-silico studies of hydroxyxanthone derivatives as potential pfDHFR and pfDHODH inhibitor by molecular docking, molecular dynamics simulation, MM-PBSA calculation and …
LP Hastuti, F Hermawan, MR Iresha, T Ernawati
Informatics in Medicine Unlocked 47, 101485, 2024
2024
A MOLECULAR DOCKING STUDY OF EPOXYXANTHONES TOWARD NON-SMALL AND SMALL CELL LUNG CANCER TARGET PROTEINS
MR Iresha, J Jumina, HD Pranowo, EN Sholikhah, F Hermawan
2022
系统目前无法执行此操作,请稍后再试。
文章 1–8